BRIEF-Ultragenyx Pharma Says EC Expands Evkeeza Approval For HoFH To Children As Young As 6 Months

Reuters
06 Jan
BRIEF-Ultragenyx Pharma Says EC Expands Evkeeza Approval For HoFH To Children As Young As 6 Months

Jan 6 (Reuters) - Ultragenyx Pharmaceutical Inc RARE.O:

  • EUROPEAN COMMISSION EXTENDS APPROVAL OF EVKEEZA TO CHILDREN AS YOUNG AS 6-MONTHS OLD WITH HOFH

Source text: ID:nGNEbspFcM

Further company coverage: RARE.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10